Candriam S.C.A. Novo Nordisk A S Transaction History

Candriam S.C.A.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $521,948 - $627,648	3,944 New	3,944 $627,000
Q2 2022 Aug 03, 2022	SELL	$103.24 - $121.81 $2,168 - $2,558	-21 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $1,955 - $2,363	21 New	21 $2,000
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $2,205 - $2,692	-23 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$84.42 - $106.62 $422 - $533	-5 Reduced 17.86%	23 $2,000
Q2 2021 Jul 20, 2021	SELL	$67.66 - $84.76 $67 - $84	-1 Reduced 3.45%	28 $2,000
Q1 2021 Apr 29, 2021	BUY	$67.06 - $75.82 $67 - $75	1 Added 3.57%	29 $2,000
Q4 2020 Jan 22, 2021	BUY	$63.89 - $73.8 $383 - $442	6 Added 27.27%	28 $2,000
Q3 2020 Oct 19, 2020	SELL	$63.69 - $70.22 $1.57 Million - $1.73 Million	-24,581 Reduced 99.91%	22 $2,000
Q2 2020 Jul 23, 2020	BUY	$58.54 - $67.94 $89,214 - $103,540	1,524 Added 6.6%	24,603 $1.61 Million
Q1 2020 May 26, 2020	BUY	$49.46 - $64.78 $2,324 - $3,044	47 Added 0.2%	23,079 $1.31 Million
Q4 2019 Jan 21, 2020	BUY	$49.86 - $58.26 $1.15 Million - $1.34 Million	22,988 Added 52245.45%	23,032 $1,000
Q3 2019 Oct 21, 2019	BUY	$47.54 - $53.43 $95 - $106	2 Added 4.76%	44 $2,000
Q2 2019 Aug 01, 2019	BUY	$46.79 - $52.47 $327 - $367	7 Added 20.0%	42 $2.14 Million
Q1 2019 May 02, 2019	BUY	$46.36 - $52.63 $1,622 - $1,842	35 New	35 $1.83 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.